Related Experiment Video
Updated: Oct 30, 2025

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
Published on: January 17, 2025
A review of ECMO for cardiac arrest
Tyler E Klee1, Karl B Kern1,2
1University of Arizona College of Medicine, Tucson, AZ, United States.
Insights
Extracorporeal cardiopulmonary resuscitation (ECPR) using venoarterial extracorporeal membrane oxygenation (VA-ECMO) is a promising therapy for cardiac arrest. This review explores ECPR
Area of Science:
- Cardiology
- Critical Care Medicine
- Emergency Medicine
Background:
- Cardiac arrest presents a significant public health challenge with high mortality rates.
- Numerous underlying causes contribute to cardiac arrest, necessitating advanced treatment strategies.
- Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is an emerging mechanical device for cardiac arrest management.
Purpose of the Study:
- To review the application of extracorporeal cardiopulmonary resuscitation (ECPR) in both in-hospital and out-of-hospital cardiac arrest scenarios.
- To summarize the current progress and utilization of ECPR for refractory cardiac arrest.
- To discuss the expected outcomes associated with ECPR therapy.
Main Methods:
- This is a narrative review.
- Literature search on extracorporeal cardiopulmonary resuscitation (ECPR) and venoarterial extracorporeal membrane oxygenation (VA-ECMO).
- Synthesis of existing research on ECPR for cardiac arrest.
Main Results:
- Extracorporeal cardiopulmonary resuscitation (ECPR) is increasingly used for refractory cardiac arrest.
- There is limited randomized controlled trial data on ECPR, with one published trial.
- Significant advancements have been made in the implementation of ECPR.
Conclusions:
- ECPR represents a significant advancement in the treatment of cardiac arrest.
- Further research, including randomized controlled trials, is needed to fully establish ECPR's efficacy.
- ECPR offers a potential therapeutic option for improving outcomes in cardiac arrest patients.
Abstract:
Cardiac arrest is an important public health concern, affecting an estimated 356,500 people in the out-of-hospital setting and 209,000 people in the in-hospital setting each year. The causes of cardiac arrest include acute coronary syndromes, pulmonary embolism, dyskalemia, respiratory failure, hypovolemia, sepsis, and poisoning among many others. In order to tackle the enormous issue of high mortality among sufferers of cardiac arrest, ongoing research has been seeking improved treatment protocols and novel therapies. One of the mechanical devices that has been increasingly utilized for cardiac arrest is venoarterial extracorporeal membrane oxygenation (VA-ECMO). Presently there is only one published randomized controlled trial examining the use of VA-ECMO as part of cardiopulmonary resuscitation (CPR), a process referred to as extracorporeal cardiopulmonary resuscitation (ECPR). Recently there has been significant progress in providing ECPR for refractory cardiac arrest patients. This narrative review seeks to outline the use of ECPR for both in-hospital and out-of-hospital cardiac arrest, as well as provide information on the expected outcomes associated with its use.
Related Concept Videos
Cardiopulmonary Resuscitation II: ACLS Airway Management
Cardiopulmonary Resuscitation IV: Pharmacological Management
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Cardiopulmonary Resuscitation I: Adult
Cardiopulmonary Resuscitation III: AED Use

